Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours

Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats

(2013) Angelo Pietro Femia et al.   INTERNATIONAL JOURNAL OF CANCER

Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells

(2012) Anna Fialová et al.   INTERNATIONAL JOURNAL OF CANCER

An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis

(2012) Cecelia C. Yates-Binder et al.   PLoS One

The emerging role of CXC chemokines in epithelial ovarian cancer

(2012) Adam Rainczuk et al.   REPRODUCTION

Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study

(2011) Shih-Wei Lai et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects

(2011) Ute Bank et al.   BIOLOGICAL CHEMISTRY

The impact of diabetes on survival in women with ovarian cancer

(2011) Arvind Bakhru et al.   GYNECOLOGIC ONCOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Effect of posttranslational processing on the in vitro and in vivo activity of chemokines

(2010) Anneleen Mortier et al.   EXPERIMENTAL CELL RESEARCH

The dipeptidyl peptidase IV family in cancer and cell biology

(2010) Denise M. T. Yu et al.   FEBS Journal

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV

(2010) Armanda Casrouge et al.   JOURNAL OF CLINICAL INVESTIGATION

Post-Translational Modifications and Protein-Specific Isoforms in Endometriosis Revealed by 2D DIGE

(2010) Andrew N. Stephens et al.   JOURNAL OF PROTEOME RESEARCH

Proteomic Approach Identifies Alterations in Cytoskeletal Remodelling Proteins during Decidualization of Human Endometrial Stromal Cells

(2010) Sarah G. Paule et al.   JOURNAL OF PROTEOME RESEARCH

CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3

(2010) Gabriele S. V. Campanella et al.   PLoS One

Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: Implications for chemotaxis

(2009) Helen Denney et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells

(2009) Hiroaki Kajiyama et al.   CANCER SCIENCE

Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation

(2008) T. Loos et al.   BLOOD

Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8

(2008) Katerina Ajami et al.   FEBS LETTERS

Matrix Metalloproteinase Processing of CXCL11/I-TAC Results in Loss of Chemoattractant Activity and Altered Glycosaminoglycan Binding

(2008) Jennifer H. Cox et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

(2008) Martin Köbel et al.   PLOS MEDICINE

Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma

(2007) Markéta Tomšová et al.   GYNECOLOGIC ONCOLOGY